Convergence Seminar
Monday, September 23, 2024

Dan A. Landau, MD, PhD

Professor of Medicine, Weill Cornell Medicine
Core Member, New York Genome Center

This event has been canceled. Watch for a rescheduled date in the future.

Dan Landau and his lab study primarily human cancer which constitutes a unique phenomenon in evolutionary biology – ‘reverse engineering’ whereby cells rescind the multicellular contract and evolve to more closely resemble unicellular organisms. Importantly, the evolutionary plasticity of cancer imposes significant limitations on the potential of cancer therapies. Landau’s goal is to chart a roadmap of the basic dimensions that determine the course of cancer evolution, in order to devise therapies that directly anticipate and address tumor evolution. He has pioneered the study of intra-tumoral genetic and epigenetic diversity in patient samples to enable the study of cancer evolution in its natural environment.

Details

Dates
September 23, 2024
Time
11:00am-12:00pm PDT
Location
Mahley Auditorium & Online
Audience
Gladstone and UCSF
Contact(s)





The Convergence Seminar is organized by Gladstone’s Institute for Data Science and Biotechnology. This seminar series brings together scientists from varying disciplines to solve complex scientific questions and accelerate the path to cures.

Diversity, Equity, and Inclusion

At Gladstone, we are committed to providing events and professional development activities that resonate with our community’s diverse members. Our goal is to develop creative programming that encompasses a wide variety of ideas and perspectives to inspire, educate, and engage with everyone within our walls.

We want to effect positive change through our events and activities by providing a platform for discussions on important topics related to increasing diversity and inclusiveness in the sciences.